• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗肿瘤肽拮抗剂[Arg6,D-Trp7,9,MePhe8]P物质(6-11)降解产物的结构鉴定

Structural identification of the degradation products of the antitumor peptide antagonist [Arg6,D-Trp7,9,MePhe8]substance P (6-11).

作者信息

Reubsaet J L, Beijnen J H, Bult A, Hop E, Vermaas R, Kellekule Y, Kettenes-van den Bosch J J, Underberg W J

机构信息

Faculty of Pharmacy, Universiteit Utrecht, The Netherlands.

出版信息

Anal Chem. 1995 Dec 1;67(23):4431-6. doi: 10.1021/ac00119a036.

DOI:10.1021/ac00119a036
PMID:8633781
Abstract

The basic hexapeptide antagonist [Arg6,D-Trp7,9,MePhe8]-substance P (6-11) was degraded in acid and alkaline media. In acid solution, only one degradation product is found whereas in alkaline solution at least six products are formed. These compounds were analytically characterized and structurally identified by reversed-phase high-performance liquid chromatography, capillary electrophoresis, liquid chromatography/mass spectrometry, fast atom bombardment tandem mass spectrometry, optical rotation analysis, and chiral gas chromatography. The product formed in acidic solution is the terminally deamidated antagonist [Arg6,D-Trp7,9,MePhe8]substance P (6-11); this product was also found in alkaline degradation mixtures. Other important degradation products originate from racemization of the amino acid residue L-Met, formation of ornithine from Arg, and the oxidation of Met to its sulfoxide form.

摘要

基本的六肽拮抗剂[精氨酸6,D-色氨酸7,9,甲基苯丙氨酸8]-P物质(6-11)在酸性和碱性介质中会发生降解。在酸性溶液中,仅发现一种降解产物,而在碱性溶液中至少会形成六种产物。通过反相高效液相色谱法、毛细管电泳法、液相色谱/质谱法、快原子轰击串联质谱法、旋光分析和手性气相色谱法对这些化合物进行了分析表征和结构鉴定。在酸性溶液中形成的产物是末端脱酰胺化的拮抗剂[精氨酸6,D-色氨酸7,9,甲基苯丙氨酸8]P物质(6-11);该产物在碱性降解混合物中也被发现。其他重要的降解产物源自氨基酸残基L-蛋氨酸的消旋化、精氨酸形成鸟氨酸以及蛋氨酸氧化为其亚砜形式。

相似文献

1
Structural identification of the degradation products of the antitumor peptide antagonist [Arg6,D-Trp7,9,MePhe8]substance P (6-11).抗肿瘤肽拮抗剂[Arg6,D-Trp7,9,MePhe8]P物质(6-11)降解产物的结构鉴定
Anal Chem. 1995 Dec 1;67(23):4431-6. doi: 10.1021/ac00119a036.
2
Reversed-phase high-performance liquid chromatography and capillary electrophoresis in the stability study of the neuropeptide growth factor antagonist [Arg6,D-Trp7,9,MePhe8]-substance P (6-11): a comparative study.反相高效液相色谱法和毛细管电泳法用于神经肽生长因子拮抗剂[Arg6,D-Trp7,9,MePhe8]-P物质(6-11)稳定性研究的比较
Anal Biochem. 1994 Jul;220(1):98-102. doi: 10.1006/abio.1994.1304.
3
Pharmaceutical development of a parenteral lyophilized formulation of the investigational antitumor neuropeptide antagonist [Arg6, D-Trp7,9, MePhe8]-Substance P [6-11].研究性抗肿瘤神经肽拮抗剂[Arg6, D-Trp7,9, MePhe8]-P物质[6-11]的肠胃外冻干制剂的药物研发
Invest New Drugs. 1998;16(2):99-111. doi: 10.1023/a:1006041024109.
4
Precolumn fluorescence derivatization of the antagonist [Arg6,D-Trp7,9,MePhe8]-substance P[6-11] with benzoin in high-performance liquid chromatography and selective detection of arginine-containing fragments in its degradation products.高效液相色谱中拮抗剂[精氨酸6,D-色氨酸7,9,甲基苯丙氨酸8]-P物质[6-11]与安息香的柱前荧光衍生化及其降解产物中含精氨酸片段的选择性检测。
J Chromatogr A. 1996 Jun 7;736(1-2):91-6. doi: 10.1016/0021-9673(95)01359-8.
5
Degradation kinetics of antagonist [Arg6, D-Trp7,9, MePhe8]-substance P [6-11] in aqueous solutions.拮抗剂[精氨酸6,D-色氨酸7,9,甲基苯丙氨酸8]-P物质[6-11]在水溶液中的降解动力学
Anal Biochem. 1995 May 20;227(2):334-41. doi: 10.1006/abio.1995.1289.
6
Stability and in vitro metabolism of the mitogenic neuropeptide antagonists [D-Arg1,D-Phe5, D-Trp7,9, Leu11]-substance P and [Arg6, D-Trp7,9, MePhe8]-substance P (6-11) characterized by high-performance liquid chromatography.通过高效液相色谱法对促有丝分裂神经肽拮抗剂[D-精氨酸1,D-苯丙氨酸5,D-色氨酸7,9,亮氨酸11]-P物质和[精氨酸6,D-色氨酸7,9,甲基苯丙氨酸8]-P物质(6-11)的稳定性及体外代谢进行了表征。
J Pharm Biomed Anal. 1994 Jun;12(6):811-9. doi: 10.1016/0731-7085(93)e0027-k.
7
Determination of two neuropeptide growth factor antagonists, [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-substance P and [Arg6,D-Trp7,9,N-MePhe8]- substance P(6-11), by high-performance liquid chromatography with electrochemical detection.
J Chromatogr B Biomed Appl. 1994 Mar 4;653(2):195-203. doi: 10.1016/0378-4347(93)e0442-s.
8
Development of a gradient elution high-performance liquid chromatography assay with ultraviolet detection for the determination in plasma of the anticancer peptide [Arg6, D-Trp7,9, mePhe8]-substance P (6-11) (antagonist G), its major metabolites and a C-terminal pyrene-labelled conjugate.
J Chromatogr B Biomed Sci Appl. 1999 Sep 24;732(2):277-85. doi: 10.1016/s0378-4347(99)00294-7.
9
Qualitative and quantitative aspects of the degradation of several tripeptides derived from the antitumour peptide antagonist [Arg(6), D-Trp(7,9), MePhe(8)] substance P[6-11].
J Pharm Biomed Anal. 1999 Mar;19(3-4):277-84. doi: 10.1016/s0731-7085(98)00115-0.
10
Metabolism of the broad-spectrum neuropeptide growth factor antagonist: [D-Arg1, D-Phe5, D-Trp7,9, Leu11]-substance P.广谱神经肽生长因子拮抗剂:[D-精氨酸1,D-苯丙氨酸5,D-色氨酸7,9,亮氨酸11] - P物质的代谢
Br J Cancer. 1996 Mar;73(6):715-20. doi: 10.1038/bjc.1996.126.

引用本文的文献

1
Identification and Detection of Bioactive Peptides in Milk and Dairy Products: Remarks about Agro-Foods.牛奶和乳制品中生物活性肽的鉴定和检测:对农业食品的评价。
Molecules. 2020 Jul 22;25(15):3328. doi: 10.3390/molecules25153328.
2
Pharmaceutical development of a parenteral lyophilized formulation of the investigational antitumor neuropeptide antagonist [Arg6, D-Trp7,9, MePhe8]-Substance P [6-11].研究性抗肿瘤神经肽拮抗剂[Arg6, D-Trp7,9, MePhe8]-P物质[6-11]的肠胃外冻干制剂的药物研发
Invest New Drugs. 1998;16(2):99-111. doi: 10.1023/a:1006041024109.